| |
 |
|
|
Inventor: Haynes; Joel
Address: Middleton, WI
No. of patents: 5
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 5912338 |
Nucleic acids encoding self-assembled, non-infectious, non-replicating, immunogenic retrovirus-l |
June 15, 1999 |
| This invention is directed toward nucleic acids encoding self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV-1 genomes devoid of long terminal repeats and containing nucleotide sequences encoding chimeric envelope glycoproteins. |
| 5866137 |
Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprisin |
February 2, 1999 |
| This invention is directed toward self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV-1 genomes devoid of long terminal repeats and containing nucleotide sequences encoding chimeric envelope glycoproteins. Retrovirus-like par |
| 5849475 |
Immunoassay diagnostic kit containing antigens derived from self-assembled, non-infectious, non- |
December 15, 1998 |
| This invention is directed toward diagnostic kits and antigens useful for the detection of viral antigens in a test sample. The kit contains antigens obtained from self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV-1 genomes |
| 5571712 |
Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a |
November 5, 1996 |
| This invention is directed towards nucleic acid molecules capable of producing human immunodeficiency virus (HIV) retrovirus-like particles, which are non-infectious, replication defective, and immunogenic. Recombinant HIV genomes were generated that are devoid of long terminal repea |
| 5439809 |
Non-infectious HIV particles lacking long terminal repeats |
August 8, 1995 |
| An immunogenic HIV retrovirus-like particle which is non-infectious and non-replicating and which is useful as a candidate vaccine component against HIV infection, is produced by genetic engineering. A DNA molecule comprising the HIV genome devoid of long terminal repeats is incorporated |
|
|
|
